Safety, Tolerability, and Immunogenicity of Revaccination With mRNA-1345 RSV Vaccine Administered 24 Months Following a Primary Dose in Adults >/=60 Years of Age. (academic.oup.com)

Authors: Desai M … Priddy F Journal: Journal of Infectious Diseases Published: 2026-07-09 DOI: https://doi.org/10.1093/infdis/jiag350